Cargando…
Dopamine receptor agonists mechanism of actions on glucose lowering and their connections with prolactin actions
Robust experiment evidence suggests that prolactin can enhance beta-cell proliferation and increase insulin secretion and sensitivity. Apart from acting as an endocrine hormone, it also function as an adipokine and act on adipocytes to modulate adipogenesis, lipid metabolism and inflammation. Severa...
Autores principales: | Chien, Hung-Yu, Chen, Su-Mei, Li, Wan-Chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012161/ https://www.ncbi.nlm.nih.gov/pubmed/36993818 http://dx.doi.org/10.3389/fcdhc.2023.935872 |
Ejemplares similares
-
GLP-1 receptor agonists as promising disease-modifying agents in WFS1 spectrum disorder
por: Panfili, Eleonora, et al.
Publicado: (2023) -
A Changed Gut Microbiota Diversity Is Associated With Metabolic Improvements After Duodenal Mucosal Resurfacing With Glucagon-Like-Peptide-1 Receptor Agonist in Type 2 Diabetes in a Pilot Study
por: Meiring, Suzanne, et al.
Publicado: (2022) -
Making sense of glucose sensors in end-stage kidney disease: A review
por: Williams, Mark E., et al.
Publicado: (2022) -
Evaluating a systematic intensive therapy using continuous glucose monitoring and intermittent scanning glucose monitoring in clinical diabetes care: a protocol for a multi-center randomized clinical trial
por: Ólafsdóttir, Arndís F., et al.
Publicado: (2023) -
Investigating the value of glucodensity analysis of continuous glucose monitoring data in type 1 diabetes: an exploratory analysis
por: Cui, Elvis Han, et al.
Publicado: (2023)